SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Norris Eric

(Last) (First) (Middle)
ALBEMARLE CORPORATION,
4250 CONGRESS STREET, SUITE 900

(Street)
CHARLOTTE NC 28209

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/07/2019
3. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Lithium
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (1) (1) Common Stock 4,017 118.75 D
Stock Option (2) (2) Common Stock 7,669 91 D
Restricted Stock Units (3) (4) Common Stock 1,264 (5) D
Restricted Stock Units (6) (4) Common Stock 18,228 (5) D
Restricted Stock Units (7) (4) Common Stock 2,336 (5) D
Explanation of Responses:
1. On February 23, 2018, the reporting person was granted a 10-year option exercisable for 4,017 shares of Common Stock, cliff-vesting on February 23, 2021.
2. On February 26, 2019, the reporting person was granted a 10-year option exercisable for 7,669 shares of Common Stock, cliff-vesting on February 26, 2022.
3. Restricted Stock Units granted on 2/23/2018. First 50% vests on 2/23/2021 and second 50% vests on 2/23/2022.
4. No expiration date.
5. Each Restricted Stock Unit converts to 1 share of Common Stock.
6. Restricted Stock Units granted on 3/1/2018, cliff-vesting on 3/1/2021.
7. Restricted Stock Units granted on 2/26/2019. First 50% vests on 2/26/2022 and second 50% vests on 2/26/2023.
Remarks:
Exhibit List Exhibit 24 - Power of Attorney
/s/ Ander Krupa, attorney-in-fact 05/17/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                                                                      EXHIBIT 24


                               POWER OF ATTORNEY

       Know all by these presents, that the undersigned hereby constitutes and
appoints each of Karen G. Narwold, Ander Krupa, Sarah E. Marshik and Brenda J.
Mareski, or either of them acting singly and with full power of substitution,
the undersigned's true and lawful attorney-in-fact to:

    (1)   execute for and on behalf of the undersigned, in the undersigned's
          capacity as an officer and/or director of Albemarle Corporation (the
          "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the
          Securities Exchange Act of 1934 and the rules thereunder;

    (2)   do and perform any and all acts for and on behalf of the undersigned
          that may be necessary or desirable to complete and execute any such
          Form 3, 4 or 5, complete and execute any amendment or amendments
          thereto, and timely file such form with the United States Securities
          and Exchange Commission and any stock exchange or similar authority;
          and

    (3)   take any other action of any type whatsoever in connection with the
          foregoing that, in the opinion of such attorney-in-fact, may be of
          benefit to, in the best interest of, or legally required by, the
          undersigned, it being understood that the documents executed by such
          attorney-in-fact on behalf of the undersigned pursuant
 to this Power
          of Attorney shall be in such form and shall contain such terms and
          conditions as such attorney-in-fact may approve in such attorney-in-
          fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 9th day of May, 2019.



                                                  /s/ Eric Norris
                                                  Eric Norris